The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
A Novel Design of Artificial Membrane for Improving the PAMPA Model
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reconstitution of Cell Membrane Structure in vitro and its Transformation into an Excitable System
MUELLER, P., RUDIN, D. O., TI TIEN, H., & WESCOTT, W. C. (1962) · Nature · doi:10.1038/194979a0 · Cited by 1,404
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304
High throughput artificial membrane permeability assay for blood–brain barrier
Di, L., Kerns, E. H., Fan, K., McConnell, O. J., & Carter, G. T. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00012-6 · Cited by 1,195
Wohnsland, F., & Faller, B. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001020e · Cited by 492
Intestinal Drug Absorption and Metabolism in Cell Cultures: Caco-2 and Beyond
Artursson, P., & Borchardt, R. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012155124489 · Cited by 280
Cell culture-based models for intestinal permeability: A critique
Balimane, P. V., & Chong, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03354-9 · Cited by 278
Self-citationCurrent industrial practices of assessing permeability and P-glycoprotein interaction
Balimane, P. V., Han, Y.-H., & Chong, S. (2006) · The AAPS Journal · doi:10.1208/aapsj080101 · Cited by 258
Self-citationPAMPA—critical factors for better predictions of absorption
Avdeef, A., Bendels, S., Di, L. I., Faller, B., Kansy, M., Sugano, K., & Yamauchi, Y. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21068 · Cited by 240
Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA method
Avdeef, A., Artursson, P., Neuhoff, S., Lazorova, L., Gråsjö, J., & Tavelin, S. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.11.011 · Cited by 215
Drug absorption in vitro model: filter-immobilized artificial membranes
Avdeef, A., Strafford, M., Block, E., Balogh, M. P., Chambliss, W. G., & Khan, I. A. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00191-9 · Cited by 153
PAMPA—A drug absorption in vitro model
Avdeef, A., & Tsinman, O. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.008 · Cited by 152
Advances in screening for membrane permeability: high-resolution PAMPA for medicinal chemists
Kansy, M., Avdeef, A., & Fischer, H. (2004) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2004.11.013 · Cited by 132
Prediction of human intestinal permeability using artificial membrane permeability
Sugano, K., Nabuchi, Y., Machida, M., & Aso, Y. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00161-3 · Cited by 116
Alsenz, J., & Haenel, E. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000008043.71001.43 · Cited by 110
Marino, A. M., Yarde, M., Patel, H., Chong, S., & Balimane, P. V. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.008 · Cited by 101
Self-citationDevelopment and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Zerrouk, N., & Mura, P. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.005 · Cited by 100 · cited 1×
“For example, the use of octanol as the phospholipid solvent in PAMPA has yielded higher permeability value for antipyrine (22).”
BackgroundLiu, H., Sabus, C. L., Carter, G. T., Du, C., Avdeef, A., & Tischler, M. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003380.44755.5a · Cited by 79
Development and evaluation of an in vitro method for prediction of human drug absorption
Corti, G., Maestrelli, F., Cirri, M., Furlanetto, S., & Mura, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.004 · Cited by 62
Lipid composition effect on permeability across PAMPA
Seo, P., Teksin, Z. Ş., Kao, J. P. Y., & Polli, J. E. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.012 · Cited by 58
Balimane, P. V., Pace, E., Chong, S., Zhu, M., Jemal, M., & Pelt, C. K. V. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.03.043 · Cited by 51
Self-citationDalpiaz, A., Pavan, B., Vertuani, S., Vitali, F., Scaglianti, M., Bortolotti, F., Biondi, C., Scatturin, A., Tanganelli, S., Ferraro, L., et al. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.10.014 · Cited by 35
Cited by
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 649
Bennion, B. J., Be, N. A., McNerney, M. W., Lao, V., Carlson, E. M., Valdez, C. A., Malfatti, M. A., Enright, H. A., Nguyen, T. H., Lightstone, F. C., et al. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b02914 · Cited by 280
Drug permeability profiling using cell-free permeation tools: overview and applications
Berben, P., Bauer-Brandl, A., Brandl, M., Faller, B., Flaten, G. E., Jacobsen, A.-C., Brouwers, J., & Augustijns, P. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.016 · Cited by 199
Generation of intestinal organoids derived from human pluripotent stem cells for drug testing
Yoshida, S., Miwa, H., Kawachi, T., Kume, S., & Takahashi, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-63151-z · Cited by 82
Metadata
- Authors
- Chen, X., Murawski, A., Patel, K., Crespi, C. L., & Balimane, P. V.
- Venue
- Pharmaceutical Research
- Published
- 2008-01-10
- Volume
- 25
- Issue
- 7
- Pages
- 1511-1520
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W2015811644
- Cited by
- 262
- References
- 21
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.